Seeking Alpha

Theriva Biologics Announces Orphan Drug Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Pancreatic Cancer

ROCKVILLE, Md., June 27, 2023 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a clinical-stage company developing therapeutics designed to treat cancer and ...
Becker's Hospital Review

Amgen sues FDA over drug exclusivity rights: 5 things to know

Amgen on May 25 filed a lawsuit against the Food and Drug Administration after the agency denied the drugmaker a six-month exclusivity period for its secondary hyperparathyroidism treatment Sensipar, ...
Seeking Alpha

Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis

WASHINGTON, Dec. 15, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug ...
Law

Mitsubishi Tanabe Pharma Corporation v. Shanghai Auzone Biological Technology Co., Ltd.

Mitsubishi Tanabe Pharma filed a patent infringement lawsuit against Shanghai Auzone Biological Technology and its subsidiaries on Oct. 15 in New Jersey District Court. The action, which pertains to ...